First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants
Clinical trial NCT03261401 · COMPLETED
Trial details
- NCT number
- NCT03261401
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2019-06-14
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.